Celsius: Two Brands, One Clear Growth Path — A Long Trade With Defined Risk

Hook / Thesis

Celsius has quietly moved from a niche functional-drink player into a two-brand growth company. The Alani Nu acquisition has already reshaped the revenue profile: management reported roughly 117% sales growth to $721.6 million in the most recent growth period, and EPS is recovering (an update noted 86% EPS growth to $0.26). Those are the kinds of numbers that justify a much higher multiple if distribution and margins normalize.

The market is fearful about inventory and integration noise, which shows up in volatile multiples and bouts of heavy shorting. That volatility creates a tactical buying opportunity at roughly $48.04 today. My view: if Celsius can sustain shelf gains, realize synergies from Alani Nu and modest margin expansion, the stock should trade materially higher. This is a long trade with a disciplined stop and a target near the 52-week range.

What the company does and why it matters

Celsius Holdings develops, markets and distributes functional drinks and liquid supplements, selling post-workout energy drinks and protein bars. The business model is simple: scale brands, secure retail distribution, and preserve premium pricing by marketing toward fitness-minded consumers. The Alani Nu acquisition added a second, fast-growing brand and meaningful incremental revenue, accelerating overall growth and expanding Celsius' retail footprint and demographic reach.

Investors should care because this is not pure hype growth. The company reported a sharp revenue step-up to about $721.6 million alongside EPS acceleration, and free cash flow is meaningful at roughly $523.6 million. A balance of strong cash generation and near-term growth prospects creates a classic scenario where the enterprise value can meaningfully compress into a lower multiple as growth continues — provided execution is intact.

Supporting numbers and valuation framing

• Market cap sits near $12.3 billion, with an enterprise value around $13.88 billion.
• Reported free cash flow in the coverage is approximately $523.6 million, implying the market is capitalizing robust cash generation alongside growth.
• Multiple context: price-to-sales is roughly 6.5x and EV-to-sales is ~6.53x. EV-to-EBITDA is elevated at ~37.9x today, reflecting very strong growth expectations priced into the stock.
• Technicals: current price is $48.04; 10-day SMA ~$49.12, 50-day SMA ~$49.50 and the MACD is showing bullish momentum while RSI sits near 46 — a neutral-to-favorable technical backdrop for an entry sized with a stop below meaningful support.

Yes, multiples look rich on headline trailing metrics. But two points matter: 1) acquisition accounting and integration-related costs can distort GAAP margins and EPS in the near-term, and 2) forward metrics already baked in by some analysts appear much more reasonable (one coverage view cited a forward P/E near ~34x). If management turns distribution momentum into steady organic growth and improves gross margins modestly, the forward multiple compresses quickly — producing the upside we seek.

Catalysts (what will move the stock)

• Distribution expansion and shelf gains in major grocery and convenience chains. The next few quarters of reported SKU and point-of-sale traction will be key.
• Successful integration of Alani Nu: visible synergies in SG&A and supply chain that improve consolidated margins.
• Quarterly guidance that narrows the range and points to sustained revenue growth above 30-40% year-over-year (given the recent step-up, any re-acceleration is material).
• International rollout picking up: currently a small share of revenue, but any visible lift from international channels could re-rate the name.
• Analyst upgrades and institutional interest once inventory/waterfall concerns abate — the stock has shown quick moves on positive research notes previously.

Trade plan - actionable and time-bound

Why these levels?

The entry tracks the current market price, keeping slippage minimal. The stop at $40 sits below a structural support zone and gives the thesis room to play out while strictly limiting downside to a defined amount. The $65 target is below the prior 52-week high of $66.74, offering a realistic upside if growth and margin trends normalize. An alternate $58 target is provided for traders who prefer partial profit-taking on earlier strength.

Risks and counterarguments

• Integration and execution risk: Acquisitions rarely go purely according to plan. If Alani Nu fails to integrate or deliver expected synergies, EPS and margin progress could stall and multiples would likely compress further.
• Distribution concentration and inventory swings: Past inventory issues with major partners can cause noisy revenue prints and elevated returns or write-downs. Another inventory mismatch would undermine confidence and disrupt the revenue cadence.
• Competitive pressure: The non-alcoholic energy drink category is crowded. Large incumbents can use scale and promotional dollars to defend share, pressuring pricing and margins.
• Valuation vulnerability: Headline multiples (EV/EBITDA ~37.9x, P/S ~6.5x) are high. If growth decelerates faster than expected, the multiple could re-rate down sharply, producing notable downside even with otherwise reasonable fundamentals.
• Short interest and volatility: There is material short activity and large short-volume days; that increases risk of rapid downside on negative news and also creates unpredictable short-covering rallies that can be difficult to trade.

Counterargument to the buy thesis: It is entirely plausible that the market is correctly pricing a scenario where growth slows materially once easy acquisition-fueled comparisons roll off, leaving Celsius exposed to high structural multiples. In that case, the valuation would remain stretched and downside would be meaningful even if the brand remains intact. That is why strict stop discipline and position sizing are essential.

What will change my mind?

I will reduce conviction or move to a neutral view if any of the following occur: 1) management signals persistent margin pressure with no credible path to synergies, 2) sequential distribution metrics stall for more than one quarter, or 3) inventory-related chargebacks or a major retail partner dispute reappears. Conversely, I would increase conviction if sustained organic growth above 20% is visible without promotional dilution and free cash flow margins expand meaningfully.

Bottom line: Celsius is a growth story with two brands that can realistically drive the numbers needed to justify a higher share price. The trade is long at $48.04 with a $40 stop and a $65 target over a 180-trading-day horizon. Keep position size aligned with the stop and monitor distribution and margin cadence closely.

Useful reference

Company instrument: security detail.